CA-125 and risk of malignancy index for screening for malignancy in fertile aged females with ovarian cyst, which is more cost effectiveness?
BACKGROUND
Ovarian tumor is a cause of infertility in the fertile-aged women. Also, it can also turns into malignancy and causes deadly outcome. Screening for malignancy is an important management.


OBJECTIVE
The available screening methods that are widely used at present include CA-125 determination and the risk of malignancy index (RMX), which is a combined CA-125 with ultrasonography, determination.


METHODS
Here, the author tries to assess cost-effectiveness of both alternative in screening by basic medical economics technique.


METHODS
Classical descriptive analysis was used for cost effectiveness calculation.


RESULTS
In this work, from the cost-effectiveness analysis, the CA-125 test is more cost-effectiveness than RMX.


CONCLUSIONS
This reflects that the usage of additional ultrasonography test for increasing the diagnostic activity in screening for ovarian cyst in the fertile aged females in Thailand is still not appropriate.
Wiwanitkit House, Bangkhae, Bangkok, Thailand.
Viroj
V
Wiwanitkit
CA-125; fertility; ovarian cyst; risk of malignancy index